The markers were glioma stem cell markers (CD133 and Msh1), neuronal lineage markers (nestin, sox1, sox2, and pax6), and differentiated markers (GFAP, Tuj1, and Olig123). This evidence concerns the gene GFAP and central nervous system cancer.